BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 15034229)

  • 1. Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials.
    Anderer P; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Pascual-Marqui RD
    Neuropsychobiology; 2004; 49(3):134-53. PubMed ID: 15034229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia.
    Anderer P; Semlitsch HV; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Gräser T; Oettel M
    Psychoneuroendocrinology; 2003 Apr; 28(3):419-45. PubMed ID: 12573306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA).
    Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Saletu B; Zeitlhofer J
    Sleep Med; 2009 Sep; 10(8):850-8. PubMed ID: 19342295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.
    Linzmayer L; Semlitsch HV; Saletu B; Böck G; Saletu-Zyhlarz G; Zoghlami A; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Grünberger J
    Arzneimittelforschung; 2001; 51(3):238-45. PubMed ID: 11304940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone.
    Saletu-Zyhlarz G; Anderer P; Gruber G; Mandl M; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Abu-Bakr MH; Grätzhofer E; Saletu B
    J Sleep Res; 2003 Sep; 12(3):239-54. PubMed ID: 12941063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and energetic processes related to P300: LORETA findings in depression and effects of antidepressant drugs.
    Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():85-91. PubMed ID: 12575474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA).
    Saletu B; Anderer P; Saletu-Zyhlarz GM; Gruber D; Metka M; Huber J
    Psychopharmacology (Berl); 2005 Apr; 178(4):389-99. PubMed ID: 15765254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients.
    Saletu B; Anderer P; Gruber D; Metka M; Huber J; Saletu-Zyhlarz GM
    Maturitas; 2002 Nov; 43(3):165-81. PubMed ID: 12443834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography).
    Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():121-37. PubMed ID: 12575494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
    Saletu B
    Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self vs. other: neural correlates underlying agent identification based on unimodal auditory information as revealed by electrotomography (sLORETA).
    Justen C; Herbert C; Werner K; Raab M
    Neuroscience; 2014 Feb; 259():25-34. PubMed ID: 24295635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of normal aging on sources of standard N1, target N1 and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA).
    Anderer P; Pascual-Marqui RD; Semlitsch HV; Saletu B
    Electroencephalogr Clin Neurophysiol; 1998 Mar; 108(2):160-74. PubMed ID: 9566629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection.
    Mulert C; Jäger L; Schmitt R; Bussfeld P; Pogarell O; Möller HJ; Juckel G; Hegerl U
    Neuroimage; 2004 May; 22(1):83-94. PubMed ID: 15109999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased P300 current source density in drug-naive first episode schizophrenics revealed by high density recording.
    Wang J; Tang Y; Li C; Mecklinger A; Xiao Z; Zhang M; Hirayasu Y; Hokama H; Li H
    Int J Psychophysiol; 2010 Mar; 75(3):249-57. PubMed ID: 20004691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-specific development of auditory information processing in children: an ERP study.
    Nanova P; Lyamova L; Hadjigeorgieva M; Kolev V; Yordanova J
    Clin Neurophysiol; 2008 Sep; 119(9):1992-2003. PubMed ID: 18579438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Source imaging of P300 auditory evoked potentials and clinical correlations in patients with posttraumatic stress disorder.
    Bae KY; Kim DW; Im CH; Lee SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1908-17. PubMed ID: 21843580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography.
    Anderer P; Saletu B; Wolzt M; Culic S; Assandri A; Nannipieri F; Rosini S; Saletu-Zyhlarz GM
    Hum Psychopharmacol; 2008 Apr; 23(3):243-54. PubMed ID: 18181252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cortical generators of P3a and P3b: a LORETA study.
    Volpe U; Mucci A; Bucci P; Merlotti E; Galderisi S; Maj M
    Brain Res Bull; 2007 Jul; 73(4-6):220-30. PubMed ID: 17562387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory P3a and P3b neural generators in schizophrenia: An adaptive sLORETA P300 localization approach.
    Bachiller A; Romero S; Molina V; Alonso JF; Mañanas MA; Poza J; Hornero R
    Schizophr Res; 2015 Dec; 169(1-3):318-325. PubMed ID: 26481687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auditory event related potentials and source current density estimation in phonologic/auditory dyslexics.
    Moisescu-Yiflach T; Pratt H
    Clin Neurophysiol; 2005 Nov; 116(11):2632-47. PubMed ID: 16221569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.